Phasing-in RHD genotyping.
From the Laboratory Services Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland (Drs Flegel and Tholpady); and the Department of Pathology, Virginia Commonwealth University Health System, Richmond, Virginia (Dr Roseff).
Willy A
WA
Flegel
Susan D
SD
Roseff
Ashok
A
Tholpady
D001803:Blood Transfusion / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D007159:Immunologic Tests / Q000379:methods*; D059021:Laboratory Proficiency Testing / Q000592:standards*; D010641:Phenotype; D012204:Rh-Hr Blood-Group System / Q000235:genetics*; D018029:Rho(D) Immune Globulin / Q000627:therapeutic use*
D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin; C026410:Rho(D) antigen